Fertility and Infertility — MCQs

Fertility and Infertility Indian Medical PG Practice Questions and MCQs

Question 171: Which of the following is NOT a side effect of clomiphene citrate?

A. Multiple pregnancy
B. Increased risk of ovarian cancer
C. Multiple polycystic ovaries
D. Teratogenic effects on offspring (Correct Answer)

Explanation: **Explanation:** Clomiphene Citrate (CC) is a Selective Estrogen Receptor Modulator (SERM) and the first-line drug for ovulation induction in WHO Group II anovulation (PCOS). **Why Option D is the correct answer:** Clomiphene citrate is **not teratogenic**. While it is contraindicated during pregnancy (FDA Category X) because it should not be administered once conception has occurred, extensive clinical data shows that the incidence of congenital anomalies in babies born following CC treatment is no higher than the baseline risk in the general population (~2-3%). **Analysis of Incorrect Options:** * **A. Multiple pregnancy:** CC leads to a rise in FSH, which can cause the development of more than one dominant follicle. The risk of multiple gestations (primarily twins) is approximately **5-10%**. * **B. Increased risk of ovarian cancer:** While controversial, long-term use (usually >12 cycles) has been epidemiologically linked to a slightly increased risk of borderline ovarian tumors. Current guidelines recommend limiting use to **6-12 cycles**. * **C. Multiple polycystic ovaries:** CC can cause **Ovarian Hyperstimulation Syndrome (OHSS)**, though the risk is much lower (<1%) compared to gonadotropins. It can lead to the formation of multiple follicular cysts and ovarian enlargement. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** It acts as a competitive antagonist to estrogen receptors in the hypothalamus, blocking negative feedback and increasing GnRH pulse frequency, which subsequently increases FSH and LH. * **Common Side Effects:** Vasomotor flushes (hot flashes - 10%), breast tenderness, and visual disturbances (scotomas). * **Anti-estrogenic effect:** It can cause thinning of the endometrium and thickening of cervical mucus, which may lead to a "conception-ovulation gap" (high ovulation rate but lower pregnancy rate). * **Monitoring:** The most common serious complication is OHSS; the most common side effect is hot flashes.

Question 172: A male patient presents with azoospermia. On examination, testicular size is normal, FSH is normal, and testosterone levels are normal. What is the most probable cause?

A. Maldescended testis
B. Klinefelter's syndrome
C. Kallmann's syndrome
D. Vas obstruction (Correct Answer)

Explanation: ### Explanation The clinical presentation of **azoospermia** (absence of sperm in the ejaculate) combined with **normal testicular size** and **normal hormonal profiles** (FSH, LH, and Testosterone) is the classic hallmark of **Obstructive Azoospermia**. **Why "Vas obstruction" is correct:** In obstructive azoospermia, the hypothalamic-pituitary-gonadal axis is intact, and spermatogenesis within the testes is functioning normally. Because the germinal epithelium is healthy, **FSH levels remain normal** (as Inhibin B production is not compromised). Since the Leydig cells are unaffected, **Testosterone** and testicular volume are also normal. The "blockage" is purely mechanical, occurring in the epididymis, vas deferens, or ejaculatory ducts. **Why the other options are incorrect:** * **Maldescended testis:** Usually leads to testicular atrophy and damage to the seminiferous tubules due to higher intra-abdominal temperatures, often resulting in elevated FSH and reduced testicular size. * **Klinefelter’s Syndrome (47,XXY):** This is a form of primary hypergonadotropic hypogonadism. It presents with **small, firm testes**, **elevated FSH/LH**, and low testosterone. * **Kallmann’s Syndrome:** This is hypogonadotropic hypogonadism. It presents with **low FSH/LH**, low testosterone, and prepubertal testicular volume (micropenis/small testes), often accompanied by anosmia. **High-Yield Clinical Pearls for NEET-PG:** * **FSH is the best marker for spermatogenesis:** Elevated FSH almost always indicates primary testicular failure (Non-obstructive azoospermia). * **Most common cause of Obstructive Azoospermia:** Post-inflammatory (e.g., post-gonorrheal) or Congenital Bilateral Absence of Vas Deferens (CBAVD), which is strongly associated with **Cystic Fibrosis (CFTR gene mutations)**. * **Management:** In obstructive cases, sperm can be retrieved directly from the testes/epididymis (TESA/MESA) for use in ICSI.

Question 173: A married patient for 3 years is unable to conceive despite having regular menstrual cycles. Her husband's semen analysis and hormonal profile are normal. What is the optimal timing in the menstrual cycle to perform an endometrial biopsy for infertility evaluation?

A. Days 12-14
B. Days 17-19
C. Days 20-22 (Correct Answer)
D. Days 3-5

Explanation: **Explanation:** The primary objective of an endometrial biopsy in infertility evaluation is to assess **endometrial receptivity** and confirm **ovulation**. In a standard 28-day cycle, ovulation typically occurs on Day 14. Following ovulation, the corpus luteum produces progesterone, which transforms the proliferative endometrium into secretory endometrium. **Why Days 20–22 is correct:** This period corresponds to the **mid-luteal phase** (specifically 6–8 days after ovulation). This is the "window of implantation" where progesterone levels peak. A biopsy during this time allows the pathologist to check for "secretory changes," confirming that ovulation occurred and that the endometrium is adequately prepared for an embryo. Historically, this was used for "dating" the endometrium (Noyes’ criteria), though it is now less common due to the rise of serum progesterone testing. **Analysis of Incorrect Options:** * **Days 12–14 (Option A):** This is the periovulatory/late proliferative phase. A biopsy here would only show estrogenic effects and cannot confirm if ovulation will successfully occur. * **Days 17–19 (Option B):** This is the early luteal phase. While secretory changes begin here, they are not as pronounced as in the mid-luteal phase, making it less ideal for assessing full corpus luteum function. * **Days 3–5 (Option C):** This is the early follicular/menstrual phase. The endometrium is shedding, making it unsuitable for assessing fertility or luteal adequacy. **NEET-PG High-Yield Pearls:** * **Gold Standard for Ovulation:** The most reliable single-point test for confirming ovulation is a **Serum Progesterone level >3 ng/ml** (ideally >10 ng/ml) measured on **Day 21**. * **Luteal Phase Defect (LPD):** Diagnosed if the endometrial biopsy dating lags by more than 2 days behind the actual menstrual day. * **Best time for TB Endometritis:** If investigating for Genital Tuberculosis in infertility, the biopsy should be taken from the fundus in the **late luteal phase (Day 26-28)** to maximize the yield of granulomas.

Question 174: According to the 2010 WHO criteria, what are the characteristics of normal semen analysis?

A. Volume 2.0 mL, sperm count 20 million/mL, morphology 4%, progressive motility 32%
B. Volume 1.5 mL, sperm count 15 million/mL, morphology 4%, progressive motility 32% (Correct Answer)
C. Volume 2.0 mL, sperm count 15 million/mL, morphology 40%, progressive motility 32%
D. Volume 1.5 mL, sperm count 20 million/mL, morphology 4%, progressive motility 32%

Explanation: The **WHO 2010 (5th Edition)** criteria established lower reference limits (5th centiles) for semen parameters based on fertile men whose partners had a time-to-pregnancy of less than 12 months. ### **Why Option B is Correct** Option B accurately reflects the standardized 2010 thresholds: * **Volume:** ≥ 1.5 mL * **Sperm Concentration:** ≥ 15 million/mL * **Morphology:** ≥ 4% (using Kruger’s strict criteria) * **Progressive Motility:** ≥ 32% (Total motility should be ≥ 40%) ### **Analysis of Incorrect Options** * **Option A & D:** These list a sperm count of **20 million/mL** and a volume of **2.0 mL**. These were the cut-offs for the older **WHO 1999 (4th Edition)** criteria. NEET-PG frequently tests the shift from these older, higher values to the more modern 2010 standards. * **Option C:** This suggests a **morphology of 40%**. This is clinically incorrect; under strict criteria, even 4% normal forms are considered the lower limit of "normal." ### **High-Yield Clinical Pearls for NEET-PG** * **Total Sperm Number:** The minimum total number per ejaculate is **39 million** (Volume × Concentration). * **Vitality:** At least **58%** of sperm should be alive (dye exclusion test). * **Azoospermia vs. Oligozoospermia:** Azoospermia is the total absence of sperm; Oligozoospermia is < 15 million/mL. * **Asthenozoospermia:** Progressive motility < 32%. * **Teratozoospermia:** Normal morphology < 4%. * **Note on WHO 2021 (6th Edition):** While 2010 is the standard for most exams, the 2021 update slightly adjusted volume to **1.4 mL** and concentration to **16 million/mL**, but 2010 remains the most frequently tested "gold standard" in current PG entrance patterns.

Question 175: Which of the following is NOT an essential criterion according to WHO for normal semen analysis?

A. Sperm count > 20 million/ml
B. Volume > 1.5 ml (Correct Answer)
C. Sperm with normal morphology (strict criteria) > 15%
D. Motility > 25% with rapidly progressive motility

Explanation: This question tests your knowledge of the **WHO 5th Edition (2010)** and **6th Edition (2021)** criteria for semen analysis, which are high-yield for NEET-PG. ### **Explanation of the Correct Answer** The question asks which is **NOT** an essential criterion. While **Volume > 1.5 ml** is indeed a standard WHO lower reference limit, it is technically a "correct" parameter. However, in the context of this specific MCQ format (often seen in recent exams), the options provided reflect outdated or mismatched values. According to the **WHO 5th Edition (2010)**, the lower reference limits are: * **Volume:** ≥ 1.5 ml * **Sperm Concentration:** ≥ 15 million/ml (Option A says 20, which was the 1999 criteria). * **Morphology:** ≥ 4% (Option C says 15%, which is incorrect). * **Total Motility:** ≥ 40% (Option D says 25% rapid progressive, which is an older sub-classification). In many standardized PG exams, **Option B** is marked as the "correct" answer because it is often the only value that aligns perfectly with the 2010 guidelines, whereas the others are either outdated (1999) or factually incorrect. ### **Analysis of Other Options** * **Option A (Sperm count > 20 million/ml):** This was the threshold in the **WHO 1999** guidelines. The 2010/2021 guidelines lowered this to **15 million/ml**. * **Option C (Morphology > 15%):** This is incorrect. Under Kruger’s strict criteria (WHO 2010), the cutoff is only **4%**. * **Option D (Motility > 25% rapid progressive):** The 2010 guidelines moved away from "rapidly progressive" (Grade A) and set a threshold of **32% for progressive motility** (A+B) or **40% total motility**. ### **High-Yield Clinical Pearls for NEET-PG** * **Azoospermia:** Total absence of spermatozoa in semen. * **Oligozoospermia:** Sperm count < 15 million/ml. * **Asthenozoospermia:** < 32% progressive motility. * **Teratozoospermia:** < 4% normal forms. * **Kruger’s Strict Criteria:** The gold standard for assessing morphology. * **Fructose test:** Done if there is azoospermia and low volume to check for seminal vesicle obstruction or absence.

Question 176: In which case homologous artificial insemination is used in females?

A. Hormonal disturbance
B. Tubal block
C. Cervical factor (Correct Answer)
D. All of the above

Explanation: **Explanation:** **Artificial Insemination Homologous (AIH)** involves the deliberate introduction of the husband’s processed semen into the female reproductive tract (usually intrauterine). The primary goal of AIH is to bypass barriers that prevent sperm from reaching the fallopian tubes naturally. **Why Cervical Factor is Correct:** In patients with **cervical factor infertility**, the cervical mucus may be hostile (due to antisperm antibodies) or insufficient (due to prior surgery like conization). By performing Intrauterine Insemination (IUI), the "cervical barrier" is bypassed, depositing highly motile sperm directly into the uterine cavity, significantly increasing the chances of fertilization. **Why Other Options are Incorrect:** * **Tubal Block:** This is a major contraindication for AIH/IUI. For insemination to work, at least one fallopian tube must be patent to allow the sperm and egg to meet. Patients with bilateral tubal blocks require **IVF (In Vitro Fertilization)**. * **Hormonal Disturbance:** While hormonal issues (like PCOS or anovulation) cause infertility, the primary treatment is **ovulation induction** (e.g., Clomiphene or Letrozole). AIH is only an adjunct if there is an associated male or cervical factor; it does not treat the underlying hormonal pathology. **High-Yield NEET-PG Pearls:** * **Indications for AIH:** Unexplained infertility, cervical factor, mild endometriosis, and male factors (mild oligospermia or hypospadias). * **Prerequisite:** At least one patent fallopian tube (confirmed via HSG or Laparoscopy) is mandatory. * **Semen Processing:** AIH requires "washing" the semen to remove prostaglandins, which can cause severe uterine cramping if injected directly. * **Success Rate:** Approximately 10–15% per cycle.

Question 177: All of the following are tubal patency tests EXCEPT?

A. Tubal CO2 insufflation test
B. Laparoscopy
C. Fern test (Correct Answer)
D. HSG

Explanation: **Explanation:** The **Fern test** is the correct answer because it is a test used to evaluate **ovulation and cervical mucus quality**, not tubal patency. Under the influence of high estrogen levels (just before ovulation), cervical mucus becomes thin and watery. When dried on a glass slide, it crystallizes into a "fern-like" pattern due to high sodium chloride content. Post-ovulation, progesterone inhibits this pattern. **Evaluation of Incorrect Options:** * **Tubal CO2 Insufflation (Rubin’s Test):** An older method where CO2 is introduced into the uterus. If tubes are patent, gas enters the peritoneal cavity, causing referred shoulder pain or a characteristic "hissing" sound on auscultation. * **Laparoscopy (Chromopertubation):** Considered the **Gold Standard** for assessing tubal patency. Methylene blue dye is injected through the cervix, and its spill from the fimbrial ends is directly visualized via laparoscope. * **HSG (Hysterosalpingography):** The **first-line investigation** for tubal factors. It involves injecting radiopaque dye and taking X-rays to visualize the uterine contour and tubal spill. **NEET-PG High-Yield Pearls:** * **Gold Standard for Tubal Patency:** Laparoscopy and Chromopertubation. * **First-line Screening for Tubal Patency:** HSG (usually done in the proliferative phase, Day 7–10). * **Spinnbarkeit Test:** Another cervical mucus test (measures "stretchability") used to predict the ovulatory period. * **Sonohysterosalpingography (SSG):** Uses saline and ultrasound; it is safer (no radiation) but less accurate for distal tubal blocks compared to HSG.

Question 178: What is the most common cause of male infertility?

A. Smoking
B. Varicocele (Correct Answer)
C. Epididymitis
D. Idiopathic

Explanation: **Explanation:** **Varicocele** is the most common identifiable cause of male infertility, found in approximately **35-40% of men with primary infertility** and up to 80% of men with secondary infertility. It is characterized by the abnormal dilation and tortuosity of the pampiniform plexus of veins. The primary mechanism of infertility is the **elevation of scrotal temperature**, which impairs spermatogenesis, though oxidative stress and reflux of adrenal metabolites also play roles. **Analysis of Options:** * **Varicocele (Correct):** It is the leading "correctable" and overall most common identifiable cause. It typically occurs on the left side due to the 90-degree entry of the left testicular vein into the left renal vein. * **Smoking (Incorrect):** While smoking is a significant lifestyle risk factor that reduces sperm count and motility (asthenozoospermia) due to oxidative stress, it is considered a contributing factor rather than the primary etiology. * **Epididymitis (Incorrect):** This is a common cause of *obstructive* azoospermia due to post-inflammatory scarring, but it is far less frequent than varicocele in the general infertile population. * **Idiopathic (Incorrect):** While many cases of male infertility remain unexplained (idiopathic), in the context of standardized medical examinations like NEET-PG, **Varicocele** is the established "most common cause" cited in standard textbooks (e.g., Williams, Dutta). **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** The gold standard for diagnosis is **Color Doppler Ultrasound** (showing venous diameter >2-3 mm and retrograde flow during the Valsalva maneuver). * **Semen Analysis:** Classically shows **Stress Pattern** (decreased motility, decreased count, and increased abnormal forms). * **Surgical Management:** Indications for surgery (Varicocelectomy) include palpable varicocele, abnormal semen parameters, and documented infertility. The **Subinguinal Microsurgical Varicocelectomy** is the gold standard treatment with the lowest recurrence rate.

Question 179: A 35-year-old woman presents with delayed menstrual cycles and a history of primary infertility. Laparoscopic examination reveals a normal uterus, bilateral enlarged ovaries, and normal fallopian tubes. Chromotubation shows blue dye spillage. What is the most probable cause?

A. Endometriosis
B. Polycystic Ovary Syndrome (PCOS) (Correct Answer)
C. Ovarian cyst
D. Tubo-ovarian mass

Explanation: ### Explanation The clinical presentation and laparoscopic findings point directly to **Polycystic Ovary Syndrome (PCOS)**. **1. Why PCOS is the Correct Answer:** * **Clinical History:** The patient is 35 years old with **primary infertility** and **delayed menstrual cycles** (oligomenorrhea), which are hallmark features of the chronic anovulation seen in PCOS. * **Laparoscopic Findings:** The presence of **bilateral enlarged ovaries** (often described as "oyster shell" ovaries with a thickened capsule) is a classic morphological feature. * **Tubal Patency:** **Chromotubation** showing blue dye spillage confirms that the fallopian tubes are patent. This rules out tubal factor infertility and aligns with PCOS, where infertility is primarily **ovulatory** rather than structural. **2. Why Other Options are Incorrect:** * **Endometriosis (A):** Typically presents with dysmenorrhea, pelvic pain, and "powder-burn" lesions or "chocolate cysts" on laparoscopy. It often causes tubal distortion or blockage, which would interfere with dye spillage. * **Ovarian Cyst (C):** Usually presents as a unilateral, focal enlargement rather than bilateral enlargement. A simple cyst would not typically cause a long-standing history of delayed cycles and primary infertility. * **Tubo-ovarian Mass (D):** This is usually a result of Pelvic Inflammatory Disease (PID). It involves an inflammatory mass where the tube and ovary are matted together, typically resulting in a **negative chromotubation** (no dye spillage) due to tubal occlusion. **3. NEET-PG High-Yield Pearls:** * **Rotterdam Criteria:** Diagnosis requires 2 out of 3: (1) Oligo/anovulation, (2) Clinical/biochemical hyperandrogenism, (3) Polycystic ovaries on USG (≥12 follicles or volume >10cc). * **LH:FSH Ratio:** Classically elevated (2:1 or 3:1), though no longer a primary diagnostic criterion. * **Laparoscopic Ovarian Drilling (LOD):** A surgical treatment for PCOS-related infertility resistant to Clomiphene; it reduces the androgen-producing stroma. * **Gold Standard for Tubal Patency:** Laparoscopy with chromotubation remains the gold standard.

Question 180: According to the WHO definition, what is considered a normal sperm count?

A. 10 million/ml
B. 20 million/ml (Correct Answer)
C. 40 million/ml
D. 50 million/ml

Explanation: **Explanation:** The correct answer is **20 million/ml**. This value is based on the **WHO 4th Edition (1999) criteria**, which is frequently tested in NEET-PG as the standard benchmark for "normal sperm count." According to these guidelines, a concentration below 20 million/ml is defined as **Oligozoospermia**. **Analysis of Options:** * **A (10 million/ml):** This is considered subnormal (Oligozoospermia). While pregnancy can still occur, the statistical probability of natural conception is significantly reduced. * **B (20 million/ml):** This is the traditional WHO threshold for a normal sperm concentration. (Note: The newer WHO 5th and 6th editions have lowered this to 15 million/ml, but 20 million/ml remains the classic "high-yield" answer in many Indian competitive exams unless specified otherwise). * **C & D (40-50 million/ml):** These values are well within the normal range but do not represent the *minimum* threshold defined by the WHO for a "normal" count. **High-Yield Clinical Pearls for NEET-PG:** 1. **Definitions:** * **Azoospermia:** Total absence of sperm in semen. * **Aspermia:** Absence of semen (ejaculate). * **Asthenozoospermia:** Reduced sperm motility (<50% with forward progression). * **Teratozoospermia:** <4% normal morphology (WHO 5th Ed). 2. **Normal Semen Parameters (WHO 4th Ed):** * Volume: ≥ 2.0 ml * pH: 7.2 – 8.0 * Sperm Concentration: ≥ 20 million/ml * Total Sperm Count: ≥ 40 million per ejaculate * Motility: >50% (Grade a+b) or >25% (Grade a) * Morphology: >30% normal forms (Strict criteria: >14%)

Practice by Chapter

Reproductive Physiology

Practice Questions

Evaluation of the Infertile Couple

Practice Questions

Male Factor Infertility

Practice Questions

Female Factor Infertility

Practice Questions

Ovulatory Disorders

Practice Questions

Tubal and Peritoneal Factors

Practice Questions

Uterine Factors

Practice Questions

Unexplained Infertility

Practice Questions

Assisted Reproductive Technologies

Practice Questions

Psychological Aspects of Infertility

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free